Sichuan Goldstone Asia Pharmaceutical Inc. has focused on developing the advanced plastic composite pipe technology and putting into applications. The company can provide the reinforced pipe total solution for customers from structure design, processing, engineering installation to standard documentations. Goldstone has led Chinese steel reinforced pipe industry, and participated in formulating numbers of national standards to promote the development of the industry.
  In April 2015, the company has completed IPO and listed on the Growth Enterprise Market with stock code as "300434".
  In August 2017，the company has completed the merger and acquisition of Hainan Asia Pharmaceutical Group. Hainan Asia has nearly 30 years of development, growing to be a leading pharmaceutical company located in Zhejiang and Hainan.
  We look forward to the brand-new future of great opportunities in both business areas.